DAGPORT PROLONGED RELEASE HARD CAPSULES 0.5MG
Product details
Registration number: SIN16357P
Classification: Prescription Only
Active ingredients: Tacrolimus
Strength: 0.500 mg
Dosage form: CAPSULE, EXTENDED RELEASE
Route: ORAL
Registrant: SANDOZ SINGAPORE PTE. LTD.
ATC code: L04AD02
HSA approval date: 1 November 2021
Manufacturer(s): Novartis Pharmaceutical Manufacturing LLC (Ljubljana)
Manufacturing country/countries: SLOVENIA
What are the HSA registration number and classification for DAGPORT PROLONGED RELEASE HARD CAPSULES 0.5MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16357P
Classification: Prescription Only
What active ingredients and strength are recorded for DAGPORT PROLONGED RELEASE HARD CAPSULES 0.5MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Tacrolimus
Strength: 0.500 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for DAGPORT PROLONGED RELEASE HARD CAPSULES 0.5MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: CAPSULE, EXTENDED RELEASE
Route: ORAL
Who is the recorded registrant for DAGPORT PROLONGED RELEASE HARD CAPSULES 0.5MG?
According to the HSA dataset updated 7 August 2026:
Registrant: SANDOZ SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for DAGPORT PROLONGED RELEASE HARD CAPSULES 0.5MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Novartis Pharmaceutical Manufacturing LLC (Ljubljana)
Manufacturing country/countries: SLOVENIA
Where can I look up DAGPORT PROLONGED RELEASE HARD CAPSULES 0.5MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16357P or the exact product name DAGPORT PROLONGED RELEASE HARD CAPSULES 0.5MG. The general register link does not preselect this product.
What are the source dates for this DAGPORT PROLONGED RELEASE HARD CAPSULES 0.5MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this DAGPORT PROLONGED RELEASE HARD CAPSULES 0.5MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16357P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)